Welcome and Opening Statements

• A reminder to all HC-SIG members that this meeting is being recorded
  • Videoconferencing/teleconferencing connect details are available here
    
    

• Reading of the Linux Foundation Antitrust Policy

  • Hyperledger Antitrust Slide

Introductions

• If you’re new to the group, please…

  • Introduce yourself

  • Tell us where you're geographically located

  • Share with us your interests in healthcare in general, and blockchain technologies in specific

  • Consider posting your contact information in our HC-SIG Membership Directory
  • Questions? Review our HC-SIG FAQ for answers

Special Meeting Topic: COVID-19

How can blockchain technologies have a positive impact on the identification, prevention, and management of this pandemic?

• Recent US government spending package for COVID-19 includes the following:
  • $500 million for an emergency telehealth waiver. The bill would waive certain Medicare restrictions for telehealth, including that a Medicare beneficiary can use telehealth services even if they aren’t in a rural community. “This provision would also allow beneficiaries to receive care from physicians and other practitioners in their homes,” a summary of the package said
  • $2.2 billion to the Centers for Disease Control and Prevention to help state and local health agencies. The funding would include a provision to reimburse state or local costs for corona virus response and preparedness activities from Jan. 20 to the end of this supplemental
  • Nearly $1 billion to buy drugs and medical supplies. This procurement will include $500 million for drugs, masks and personal protective equipment that can be distributed to state and local health agencies in areas that are in shortage. It also includes funding for increasing the supply of biocontainment beds, which are secured areas used for patients with highly contagious diseases
  • More than $3 billion to support the research and development of vaccines, diagnostics and other treatments for the corona virus. Any vaccine or diagnostic developed via taxpayer funds must also “be available for purchase by the federal government at a fair and reasonable price,” the summary said. The bill also enables the Department of Health and Human Services to ensure any vaccine or diagnostic can be affordable in the commercial market, but doesn’t elaborate on how.

Next Meeting

• Scheduled for Friday, 2020.04.03, 0700 Pacific Time

• Discussion: topics to add to agenda?